Testicular Cancer vs Prostate Cancer: What Are The Differences, Symptoms & Treatment

Finding a lump or experiencing unusual symptoms in such a personal area of your body can feel deeply unsettling and embarrassing to discuss.

Maybe you've noticed changes but aren't sure whether they're concerning enough to see a doctor, or perhaps you're confused about which type of cancer you might be at risk for based on your age and symptoms.

These are two completely different cancers affecting different organs, occurring at different life stages, and requiring different treatments.

Understanding the difference between testicular cancer and prostate cancer helps you recognise which symptoms need urgent attention and what questions to ask your doctor.

Introduction to prostate and testicular cancer

What organs are involved?

Your testicles are two egg-shaped glands inside the scrotum that produce sperm and testosterone, sitting outside your body below the penis. Testicular cancer develops when cells within the testicle itself transform into malignant cells and form tumours. Your prostate is a walnut-sized gland located inside your body, just below the bladder and surrounding the urethra (the tube carrying urine out). Prostate cancer develops when cells in prostate tissue undergo malignant transformation and begin multiplying uncontrollably.

These are completely separate organs with different functions, which explains why testicular cancer vs prostate cancer involves such different patient populations, symptoms, and treatment approaches.

Difference between testicular cancer and prostate cancer

The testicular cancer vs prostate cancer comparison reveals fundamental differences across multiple dimensions, including who gets affected, how it presents, and what treatments work best.

Age group at risk of testicular cancer vs prostate cancer

Testicular cancer primarily affects younger men, with peak incidence occurring between ages 15 and 40 years old. Cases in men over 50 are uncommon, and it's extremely rare in elderly men.

Causes and risk factors

Testicular cancer vs prostate cancer risk factors differ substantially:

Testicular cancer risk factors include:

• •Undescended testicle (cryptorchidism) at birth increases risk 4-8 times
• •Family history, particularly in father or brother
• •Personal history of testicular cancer in one testicle
• •White/Caucasian ethnicity (higher rates than other ethnic groups)
• •HIV infection
• •Tall stature (reasons unclear)

Importantly, lifestyle factors like smoking, diet, or exercise don't significantly influence testicular cancer risk, unlike many other cancers.

Prostate cancer risk factors include:

• •Age over 50 (most significant factor)
• •Family history of prostate cancer
• •Genetic mutations (BRCA1, BRCA2)
• •Diet high in red meat and high-fat dairy
• •Obesity
• •Smoking (associated with more aggressive disease)
• •Possible link to prostatitis (chronic prostate inflammation)

Research shows that while prostate cancer incidence is rising in India, rates remain lower than Western countries, possibly due to dietary and genetic factors.

Prostate and testicular cancer symptoms

Prostate and testicular cancer symptoms present very differently, reflecting the distinct locations and functions of these organs.

Difficulty starting urination or weak urine stream develops as prostate enlargement squeezes the urethra. Frequent urination, particularly at night (nocturia), becomes troublesome. Blood in urine or semen occasionally appears.

Prostate cancer and testicular pain rarely occur together since these are separate organs, though advanced prostate cancer can cause pelvic or back pain if it spreads to bones.

Diagnosis methods: Testicular cancer vs prostate cancer

Testicular cancer vs prostate cancer diagnostic approaches differ significantly:

Scrotal ultrasound creates detailed images showing whether a mass is solid (more concerning) or fluid-filled.

Surgical removal of the affected testicle (radical inguinal orchiectomy) provides both treatment and definitive tissue diagnosis.

Nutritional supplements curated by oncologists

A platform for cancer nutrition.
Clinically guided. Built for care.

Shop now

CT scans of chest, abdomen, and pelvis assess whether cancer has spread to lymph nodes or other organs.

PSA (prostate-specific antigen) blood test measures a protein produced by prostate cells, with elevated levels suggesting possible cancer.

Prostate biopsy using ultrasound guidance removes small tissue samples for microscopic examination, providing definitive diagnosis. MRI may be used before biopsy to identify suspicious areas requiring sampling.

Stages and spread pattern

Testicular cancer vs prostate cancer progression patterns: Testicular cancer staging:

• •Stage I means cancer is confined to the testicle itself without spread.
• •Stage II indicates spread to retroperitoneal lymph nodes (behind the abdomen).
• •Stage III means cancer has spread beyond lymph nodes to lungs, liver, brain, or other distant organs.

Testicular cancer tends to spread in predictable patterns, first to retroperitoneal lymph nodes, then to lungs and other distant sites.

This predictable spread pattern makes surveillance and treatment planning more straightforward. Prostate cancer staging:

• •Stage I-II represents cancer confined within the prostate gland itself.
• •Stage III means cancer has grown through the prostate capsule into nearby tissues.
• •Stage IV indicates spread to lymph nodes, bones, or other distant organs.

Prostate cancer commonly spreads to pelvic lymph nodes and bones (particularly spine, pelvis, and ribs) rather than lungs initially. Bone metastases cause pain and potential fractures, representing major morbidity in advanced disease.

Treatment options: Testicular cancer vs prostate cancer

• •Radical inguinal orchiectomy (surgical removal of affected testicle) serves as primary treatment for nearly all testicular cancers.
• •Retroperitoneal lymph node dissection removes lymph nodes where cancer commonly spreads first.
• •Chemotherapy is highly effective for testicular cancer, particularly platinum-based regimens like BEP (bleomycin, etoposide, cisplatin).
• •Radiation therapy treats seminoma subtype, particularly for stage II disease with lymph node involvement.
• •Surveillance (active monitoring) may be appropriate for very early-stage disease after orchiectomy.

Testicular cancer is one of the most curable cancers even when metastatic, with cure rates exceeding 95% for early-stage and 70-80% even for advanced disease.

Active surveillance monitors slow-growing, low-risk prostate cancer without immediate treatment, using regular PSA tests and periodic biopsies.

Radical prostatectomy surgically removes the entire prostate gland and surrounding tissue.

External beam radiation therapy or brachytherapy (radioactive seed implants) treats localised prostate cancer effectively. Hormone therapy (androgen deprivation therapy) slows cancer growth by reducing testosterone, which fuels prostate cancer cells.

Chemotherapy is typically reserved for advanced prostate cancer not responding to hormone therapy. Newer treatments include immunotherapy, targeted therapy, and radiopharmaceuticals for metastatic disease.

Prostate or testicular cancer: How doctors differentiate

When symptoms appear, how do doctors determine prostate or testicular cancer versus other conditions causing similar symptoms?

For testicular symptoms

Your doctor examines both testicles carefully, comparing size, firmness, and texture between them. Any hard lump within the testicle itself raises immediate concern for cancer. Importantly, conditions like epididymitis (infection) or hydrocele (fluid collection) can mimic cancer but feel different on examination and respond to appropriate treatment.

Testicular cancer lumps are typically painless, firm, and don't transilluminate (light doesn't pass through) unlike fluid-filled cysts.

For urinary or pelvic symptoms

Digital rectal examination allows assessment of prostate size, texture, and symmetry. Hard nodules or irregular areas suggest cancer, while a uniformly enlarged, rubbery prostate suggests benign enlargement.

PSA testing provides additional information, though elevated PSA isn't specific to cancer and can occur with infection, enlargement, or recent ejaculation. The combination of examination findings plus PSA levels guides whether biopsy is needed.

Why self-examination matters for testicular cancer vs prostate cancer

Regular testicular self-examination helps young men detect lumps early when testicular cancer is most curable. Performing monthly checks after a warm shower when the scrotum is relaxed allows you to notice any changes promptly. For prostate cancer, there's no self-examination, which is why discussing PSA screening with your doctor after age 50 (or 40-45 if you have risk factors) becomes important for early detection.

Conclusion on testicular cancer vs prostate cancer

Understanding testicular cancer vs prostate cancer distinctions helps you recognise which symptoms need attention and what to expect if either diagnosis occurs.

Testicular cancer and prostate cancer rarely occur in the same age group, making age alone a major distinguishing factor. Symptoms differ markedly, with testicular cancer causing painless testicular lumps whilst prostate cancer produces urinary symptoms or remains asymptomatic until detected through screening.

If you notice any concerning symptoms including testicular lumps, persistent urinary changes, blood in urine or semen, or pelvic pain, don't delay seeking evaluation. Both cancers are highly treatable when caught early, but delays can reduce treatment effectiveness.